Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

作者: Bradley G. Thompson , Matthew C. Coffey , Donald Morris

DOI:

关键词:

摘要: Reovirus can be used to selectively remove ras-mediated neoplastic cells from a cellular composition. It is of particular interest purge autographs which may contain with reovirus before transplanting the back into recipient, thereby reducing risk introducing or reintroducing recipient.

参考文章(95)
Elizabeth J. Shpall, C. Fred LeMaistre, Kent Holland, Edward Ball, Roy B. Jones, Rein Saral, Cindy Jacobs, Shelly Heimfeld, Ronald Berenson, Richard Champlin, A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood. ,vol. 90, pp. 4313- 4320 ,(1997) , 10.1182/BLOOD.V90.11.4313
L L Nielsen, D C Maneval, P53 tumor suppressor gene therapy for cancer. Cancer Gene Therapy. ,vol. 5, pp. 52- 63 ,(1998)
Arnold B. Rabson, Hsin-Ching Lin, Marion Bodkin, Roger Strair, HIV-1 vectors ,(1995)
Robert L. Martuza, Herbert J. Manz, Samuel D. Rabkin, Takahito Yazaki, Treatment of Human Malignant Meningiomas by G207, a Replication-competent Multimutated Herpes Simplex Virus 1 Cancer Research. ,vol. 55, pp. 4752- 4756 ,(1995)
David Francis Stojdl, Conrad J. Heilman, Michael S. Roberts, Brian D. Lichty, John C. Bell, Robert M. Lorence, Harold L. Atkins, Purging of cells using viruses ,(2001)
Bradley G. Thompson, Matthew C. Coffey, Donald Morris, Virus clearance of neoplastic cells from mixed cellular compositions ,(2011)
Masato Yamamoto, Yasuo Adachi, Shyuichiro Matsubara, Koichi Takayama, Minghui Wang, David T. Curiel, Takashi Muramatsu, Paul N. Reynolds, A Midkine Promoter-based Conditionally Replicative Adenovirus for Treatment of Pediatric Solid Tumors and Bone Marrow Tumor Purging Cancer Research. ,vol. 61, pp. 7882- 7888 ,(2001)
David F. Stojdl, Brian Lichty, Shane Knowles, Ricardo Marius, Harold Atkins, Nahum Sonenberg, John C. Bell, Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nature Medicine. ,vol. 6, pp. 821- 825 ,(2000) , 10.1038/77558